Durable efficacy of selpercatinib in patients (pts) with medullary thyroid cancer (MTC): Update of the LIBRETTO-001 trial Meeting Abstract
| Authors: | Kroiss, M.; Sherman, E.; Wirth, L. J.; Cabanillas, M. E.; Robinson, B.; Subbiah, V.; Drilon, A.; Godbert, Y.; Fasnacht, N.; Soldatenkova, V.; Xia, M. S.; Duann, C. W.; Wright, J.; Shah, M. |
| Abstract Title: | Durable efficacy of selpercatinib in patients (pts) with medullary thyroid cancer (MTC): Update of the LIBRETTO-001 trial |
| Meeting Title: | 5th Swiss Oncology and Hematology Congress (SOHC) |
| Journal Title: | Swiss Medical Weekly |
| Volume: | 152 |
| Issue: | Suppl. 265 |
| Meeting Dates: | 2022 Nov 16-18 |
| Meeting Location: | Basel, Switzerland |
| ISSN: | 1424-7860 |
| Publisher: | E M H Swiss Medical Publishers Ltd |
| Date Published: | 2022-11-14 |
| Start Page: | 46S |
| End Page: | 47S |
| Language: | English |
| ACCESSION: | WOS:000912385900072 |
| PROVIDER: | wos |
| DOI: | 10.57187/smw.2022.40034 |
| Notes: | Meeting Abstract: 86 -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
